⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11338534 | 0.75 | — | — | |
| SCHEMBL27697605 | 0.73 | — | — | |
| SCHEMBL3931468 | 0.71 | — | — | |
| SCHEMBL15078011 | 0.69 | — | — | |
| SCHEMBL23367738 | 0.68 | CACNA1H (0.34) | — | |
| SCHEMBL24925793 | 0.65 | — | — | |
| SCHEMBL3573584 | 0.64 | — | — | |
| SCHEMBL18105273 | 0.62 | — | — | |
| SCHEMBL9946998 | 0.62 | HSD17B10 (0.33) | — | |
| SCHEMBL17790242 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11365196-B2 | FGFR inhibitor and application thereof | BETTA PHARMACEUTICALS CO., LTD. (CN) | 2022-06-21 | — | — | US | disclosed |
| US-20210130353-A1 | FGFR INHIBITOR AND APPLICATION THEREOF | BETTA PHARMACEUTICALS CO., LTD. (CN) | 2021-05-06 | — | — | US | disclosed |